Location History:
- Karnataka, IN (2013 - 2018)
- Bengaluru, IN (2015 - 2024)
Company Filing History:
5 out of 111 
3 out of 22 
1 out of 1 Years Active: 2013-2024
Title: Monalisa Chatterji - A Pioneer in Monoclonal Antibody Research
Introduction
Monalisa Chatterji is an esteemed inventor based in Karnataka, India, recognized for her significant contributions in the field of biotechnology. With a total of seven patents to her name, she has made remarkable strides in monoclonal antibody development, particularly focusing on her innovative approaches to therapeutic applications.
Latest Patents
Her latest patent, titled "Monoclonal antibody and a method thereof," relates to a humanized IgG1 isotype anti-CD6 antibody (T1h). This invention specifically binds to the Scavenger receptor cysteine-rich (SRCR) domain 1 (D1) of CD6, a protein present on the surface of thymic epithelial cells, monocytes, activated T cells, and various other cell types. This advancement holds significant potential for therapeutic interventions in immunological diseases.
Career Highlights
Throughout her career, Monalisa has worked with notable organizations including Biocon Limited and Centro de Inmunologia Molecular. Her experience at these esteemed companies has not only enriched her knowledge but also provided her with a platform to further her research initiatives in biotechnology and immunology.
Collaborations
Monalisa has collaborated with talented professionals in her field, including Ramakrishnan Melarkode and Pradip Nair. These collaborations have been instrumental in advancing her research and enhancing the efficacy of her innovations in monoclonal antibodies.
Conclusion
Monalisa Chatterji exemplifies the spirit of innovation and dedication in biotechnology. Her work on monoclonal antibodies, particularly her latest inventions, underscores the importance of research in developing therapeutic solutions. With her continuing efforts and collaborations, she is poised to make further impactful contributions to the field.